Novel Bone-targeted Agents for Treatment of Osteoporosis

被引：0
|
作者：
Jun Bo WANG
机构：
来源：
Chinese Chemical Letters | 2005年 / 07期
关键词：
Osteoporosis; bone-targeted; raloxifene; bisphosphonate;
D O I：
暂无
中图分类号：
R58 [内分泌腺疾病及代谢病];
学科分类号：
摘要：
The novel bone-targeted agents were designed and synthesized by the combination of raloxifene and bisphosphonates. The anti-osteoporosis effect was evaluated by bone mineral density (BMD) obtained from OVX mice in vivo. The results indicated that the compound 8, 9 not only prevented ovariectomy induced loss of bone but also enhanced BMD to 0.87% and 19.67% compared to Sham, respectively.
引用
收藏
页码：859 / 862
页数：4
相关论文
共 50 条
  • [21] The Role of Novel Bone Forming Agents in the Treatment of Osteoporosis
    Patel, Hansita B.
    Lyerly, Lynsie J.
    Horlen, Cheryl K.
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (06) : 952 - 961
  • [22] Novel Treatment Option for Rheumatoid Arthritis through Bone-Targeted Delivery of Novokinin
    Ranjit, Arina
    Khajehpour, Sana
    Aghazadeh-Habashi, Ali
    FASEB JOURNAL, 2022, 36
  • [23] Safety Considerations for Use of Bone-Targeted Agents in Patients With Cancer
    Mortimer, Joanne E.
    Pal, Sumanta Kumar
    SEMINARS IN ONCOLOGY, 2010, 37 (03) : S66 - S72
  • [24] Near-Infrared Contrast Agents for Bone-Targeted Imaging
    Jin Seok Jung
    Danbi Jo
    Gayoung Jo
    Hoon Hyun
    Tissue Engineering and Regenerative Medicine, 2019, 16 : 443 - 450
  • [25] Bisphosphonate- Modified PEG-NELL, a Novel Bone-Targeted Molecule, as a Systemic Therapy for Osteoporosis
    Zhang, Y.
    Tanjaya, J.
    Kwak, J.
    Shi, J.
    Li, C.
    Lee, S.
    Yu, M.
    Dong, R.
    Chen, E.
    Zhang, X.
    Soo, C.
    Wu, B.
    Ting, K.
    TISSUE ENGINEERING PART A, 2016, 22 : S40 - S40
  • [26] Near-Infrared Contrast Agents for Bone-Targeted Imaging
    Jung, Jin Seok
    Jo, Danbi
    Jo, Gayoung
    Hyun, Hoon
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2019, 16 (05) : 443 - 450
  • [27] Remote-controllable bone-targeted delivery of estradiol for the treatment of ovariectomy-induced osteoporosis in rats
    Yuanyuan Guo
    Yongwei Liu
    Chen Shi
    Tingting Wu
    Yongzhi Cui
    Siyuan Wang
    Ping Liu
    Xiaobo Feng
    Yu He
    Dehao Fu
    Journal of Nanobiotechnology, 19
  • [28] Construction puerarin-based framework as a bone-targeted and pH-responsive nanomedicine for osteoporosis treatment
    Zhou, Yibiao
    Yang, Xiaowei
    Deng, Chao
    Xia, Yongjie
    Tang, Shengping
    Zeng, Hongwu
    Zhang, Bin
    Zhang, Xiaoyong
    Fu, Guibing
    You, Chao
    COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2025, 711
  • [29] Bone-targeted delivery of nanodiamond-based drug carriers conjugated with alendronate for potential osteoporosis treatment
    Ryu, Tae-Kyung
    Kang, Rae-Hyoung
    Jeong, Ki-Young
    Jun, Dae-Ryong
    Koh, Jung-Min
    Kim, Doyun
    Bae, Soo Kyung
    Choi, Sung-Wook
    JOURNAL OF CONTROLLED RELEASE, 2016, 232 : 152 - 160
  • [30] Remote-controllable bone-targeted delivery of estradiol for the treatment of ovariectomy-induced osteoporosis in rats
    Guo, Yuanyuan
    Liu, Yongwei
    Shi, Chen
    Wu, Tingting
    Cui, Yongzhi
    Wang, Siyuan
    Liu, Ping
    Feng, Xiaobo
    He, Yu
    Fu, Dehao
    JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19 (01)
12345